Anyone here know the strategy of TH1902 going forward?Isn't insane that it has not been communicated? What is the protocol amendment? What are the FDA timelines? Where are they with proof of concept? How can a CEO not want to communicate this to shareholders ?
I think they are clueless. I certainly hope I'm wrong as I'm losing big here.